Gofen & Glossberg’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $679K | Hold |
6,000
| – | – | 0.02% | 293 |
|
|
2022
Q3 | $483K | Hold |
6,000
| – | – | 0.01% | 322 |
|
|
2022
Q2 | $447K | Sell |
6,000
-32
| -0.5% | -$2.38K | 0.01% | 339 |
|
|
2022
Q1 | $771K | Hold |
6,032
| – | – | 0.02% | 269 |
|
|
2021
Q4 | $810K | Buy |
6,032
+32
| +0.5% | +$4.3K | 0.02% | 268 |
|
|
2021
Q3 | $820K | Hold |
6,000
| – | – | 0.02% | 263 |
|
|
2021
Q2 | $641K | Hold |
6,000
| – | – | 0.02% | 296 |
|
|
2021
Q1 | $539K | Hold |
6,000
| – | – | 0.01% | 317 |
|
|
2020
Q4 | $555K | Hold |
6,000
| – | – | 0.02% | 302 |
|
|
2020
Q3 | $618K | Hold |
6,000
| – | – | 0.02% | 266 |
|
|
2020
Q2 | $608K | Hold |
6,000
| – | – | 0.02% | 256 |
|
|
2020
Q1 | $404K | Hold |
6,000
| – | – | 0.02% | 290 |
|
|
2019
Q4 | $328K | Buy |
+6,000
| New | +$328K | 0.01% | 357 |
|